Research has found a potential vulnerability in the SkillTree training platform. The vulnerability could leave users’ information at risk. Further investigation is needed to determine the extent of the vulnerability and to develop potential solutions to address it.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
